• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Radiation Therapy Services Announces James Rubenstein, M.D. Appointment to American Journal of Clinical Oncology Editorial Board

Posted on: Monday, 14 August 2006, 09:00 CDT

FORT MYERS, Fla., Aug. 14 /PRNewswire-FirstCall/ -- Radiation Therapy Services, Inc. , a leading operator of radiation therapy centers, announced today that Medical Director and Secretary James Rubenstein, M.D. has been appointed to the Editorial Board of the American Journal of Clinical Oncology.

As an editor, Dr. Rubenstein will assist in reviewing incoming articles and soliciting high quality submissions from colleagues and trainees. The editorial board includes a large number of distinguished surgeons, radiation oncologists, medical oncologists, GYN oncologists, pediatric oncologists, and others who are internationally recognized for expertise in their fields. The journal emphasizes translational research, outcome studies, and cost utility analyses, and includes opinion pieces and review articles.

David Wazer, Editor in Chief of the American Journal of Clinical Oncology, said, "We believe Dr. Rubenstein will bring tremendous value to our editorial board as a practicing physician experienced in treating patients with the latest radiation oncology modalities. He is regarded as one of the top radiation oncologists and a leader in his field. We are thrilled that he has accepted our offer to join the Editorial Board."

James Rubenstein, M.D., Radiation Therapy's Medical Director, said, "The opportunity to join the Editorial Board of such a prestigious medical journal is truly an honor. I look forward to contributing to the review of research within our field and helping to ensure the Journal continues to publish some of the highest-quality articles in radiation oncology."

About the American Journal of Clinical Oncology

American Journal of Clinical Oncology is a peer-reviewed, multidisciplinary journal that publishes original articles on the latest multi-modality scientific issues related to the locoregional management of cancer. The Journal's intent is to give priority to submitted materials that deal with the surgical, radiotherapeutic and chemotherapeutic management of locoregional cancer.

About Radiation Therapy Services

Radiation Therapy Services, Inc., which operates radiation treatment centers primarily under the name 21st Century Oncology, is a provider of radiation therapy services to cancer patients. The Company's 70 treatment centers are clustered into 23 local markets in 14 states, including Alabama, Arizona, California, Delaware, Florida, Kentucky, Maryland, Massachusetts, Nevada, New Jersey, New York, North Carolina, Rhode Island and West Virginia. The Company is headquartered in Fort Myers, Florida. More information about the Company can be found at its Web site http://www.rtsx.com/. RTSXG

This release may contain forward-looking statements about the Company's future plans, expectations and objectives. Words such as "may,""will,""expect,""intend,""anticipate,""plan,""believe,""seek,""could" and "estimate" and variations of these words and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to those risk factors described in the "Risk Factors" section and other information in the Company's most recently filed quarterly report on Form 10-Q and annual report on Form 10-K, as well as the Company's other filings with the Securities and Exchange Commission which are available on the SEC's website at http://www.sec.gov/. Readers of this release are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release.

Contacts: Dave Koeninger Chief Financial Officer Radiation Therapy Services, Inc. 239-931-7282 dkoeninger@rtsx.com Investors/Media: Nick Laudico/Jason Rando The Ruth Group 646-536-7030/7025 nlaudico@theruthgroup.com jrando@theruthgroup.com

Radiation Therapy Services, Inc.

CONTACT: Dave Koeninger, Chief Financial Officer, of Radiation TherapyServices, Inc., +1-239-931-7282, dkoeninger@rtsx.com ; or Investors: NickLaudico, +1-646-536-7030, nlaudico@theruthgroup.com , or Media: Jason Rando,+1-646-536-7025, jrando@theruthgroup.com , both of The Ruth Group, forRadiation Therapy Services, Inc.

Web site: http://www.rtsx.com/

Source: PRNewswire-FirstCall

More News in this Category